← Back to news
Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic

Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic

Published: May 7, 2026 · GlobeNewswire

View original

Enables billing under traditional Medicare and creates a pathway to ~35 million Medicare Advantage beneficiaries through future payer coverage decisions Enables billing under traditional Medicare and creates a pathway to ~35 million Medicare Advantage benefic…